| | | | | | | |
 | MODERNA, INC. | -1.20% | 0.34% | -46.35% | -15.57% | 480.82% | 54 199 |
 | LONZA GROUP AG | 0.88% | 5.35% | -27.49% | -2.37% | 74.09% | 40 453 |
| IQVIA HOLDINGS INC. | -1.08% | 1.17% | -26.83% | -11.79% | 52.65% | 39 077 |
| SEAGEN INC. | 5.09% | 31.00% | -7.80% | -3.36% | 115.90% | 26 238 |
| ICON PUBLIC LIMITED COMPANY | -0.23% | 0.69% | -32.02% | -8.15% | 49.28% | 17 114 |
 | CELLTRION, INC. | -2.76% | -12.96% | -28.79% | -46.83% | -21.61% | 15 269 |
| ALNYLAM PHARMACEUTICALS, INC. | -1.27% | 1.92% | -26.37% | -7.98% | 81.68% | 15 086 |
| BIO-TECHNE CORPORATION | -1.53% | 4.34% | -30.00% | -9.78% | 79.70% | 14 227 |
 | PHARMARON BEIJING CO., LTD. | -2.57% | 1.99% | -20.95% | -34.69% | 210.63% | 12 355 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -1.95% | 1.03% | -38.64% | -29.74% | 74.91% | 11 746 |
| QIAGEN N.V. | 0.48% | 3.25% | -16.61% | -0.92% | 23.60% | 10 542 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | -2.92% | 6.87% | -32.85% | -45.11% | 82.52% | 10 525 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.28% | 69.11% | 2.02% | 101.29% | 120.45% | 9 989 |
| UNITED THERAPEUTICS CORPORATION | 0.92% | 3.67% | -14.32% | -6.44% | 108.86% | 8 386 |
| SYNEOS HEALTH, INC. | -0.21% | 0.68% | -31.87% | -18.41% | 64.92% | 7 176 |
| | | | | | | |
| | Moyenne | -0.58% | 7.90% | -25.26% | -9.32% | 106.56% | |
| | Moyenne pondérée par Capi. | -0.35% | 6.39% | -28.22% | -10.39% | 151.23% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
